$DVAX Headlines Ascena Retail shares rally after hours

New Post Public Reply Private Reply Replies (0) Message Board

Dec 29, 2013 at 10:39 AM

$DVAX Headlines

Ascena Retail shares rally after hours 4:50 p.m. Sept. 24, 2013 - Wallace Witkowski
FDA: Dynavax hep B vaccine needs more evaluation 6:49 a.m. Feb. 25, 2013 - MarketWatch.com
Dynavax Tech down 14% in premarket 7:51 a.m. Dec. 3, 2012 - Steve Gelsi
Dynavax Tech off 17% in premarket trades 7:38 a.m. Nov. 29, 2012 - Steve Gelsi
Dynavax Tech falls 49% in premarket trades 8:42 a.m. Nov. 16, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 1:42 p.m. May 9, 2012 - MarketWatch
Dynavax tumbles 24% on stock offer pricing 11:05 a.m. May 9, 2012 - Val Brickates Kennedy
Dynavax jumps 25% on FDA update 8:45 a.m. July 28, 2011 - Val Brickates Kennedy
Dynavax plunges 16% on mixed study results 10:26 a.m. July 20, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:57 p.m. Sept. 21, 2010 - MarketWatch
Drug stocks trend lower; Pfizer, Dynavax gain 2:34 p.m. Dec. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:43 p.m. Nov. 10, 2009 - MarketWatch
Dynavax to buy Symphony Dynamo 7:00 a.m. Nov. 10, 2009 - William L. Watts
Symphony to own 24% of Dynavax 6:49 a.m. Nov. 10, 2009 - Steve Goldstein
Dynavax to issue 13 million shares 6:49 a.m. Nov. 10, 2009 - Steve Goldstein
Dynavax to buy Symphony Dynamo 6:48 a.m. Nov. 10, 2009 - Steve Goldstein
Friday's biggest gaining and declining stocks 5:00 p.m. Sept. 11, 2009 - MarketWatch
Dynavax retrenches; drug stocks mixed 1:18 p.m. Sept. 11, 2009 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 4:17 p.m. Sept. 10, 2009 - MarketWatch
Dynavax, Generex rocket as drug stocks gain 1:23 p.m. Sept. 10, 2009 - Val Brickates Kennedy

Dynavax Submits Response to EMA - Analyst Blog 12:10 p.m. Dec. 24, 2013 - Zacks.com
Make Or Break Catalysts Approaching For Dynavax 8:28 a.m. Dec. 24, 2013 - Seeking Alpha
Dynavax: Embarking On A Run Propelled By 2 Potential Approvals 3:33 a.m. Dec. 19, 2013 - Seeking Alpha
Dynavax Technologies (DVAX) Catches Eye: Stock Rises 5.2% - Tale of the Tape 9:18 a.m. Nov. 25, 2013 - Zacks.com
Dynavax Technologies (DVAX) in Focus: Stock Moves 5.8% Higher - Tale of the Tape 9:18 a.m. Nov. 20, 2013 - Zacks.com
Getting Ultra-Bullish On Dynavax 6:56 a.m. Nov. 18, 2013 - Seeking Alpha
Dynavax Technologies: 6 Reasons To Buy 11:24 a.m. Nov. 17, 2013 - Seeking Alpha
Insiders Are Buying These Speculative Biotech Stocks 10:05 a.m. Nov. 11, 2013 - Seeking Alpha
Dynavax Reports In-Line Loss, Beats Rev - Analyst Blog 12:00 p.m. Nov. 8, 2013 - Zacks.com
Jefferies Reiterates on Dynavax Technologies Awaiting Initiation of HBV-23 Safety Trial 7:44 a.m. Nov. 8, 2013 - benzinga.com
Top Three Largest Insider Buys of the Past Week 4:41 p.m. Nov. 5, 2013 - GuruFocus.com
AGCO Corporation Director Buys 343K Shares and 4 Insider Buys to Note 8:10 a.m. Nov. 1, 2013 - Wall St. Cheat Sheet
Insiders Are Buying Dynavax 3:11 p.m. Oct. 31, 2013 - Seeking Alpha
Dynavax: New Phase 3 Clinical Study Finalized For HEPLISAV 4:00 a.m. Oct. 17, 2013 - Seeking Alpha
Dynavax Issues Update on HEPLISAV's Regulatory Path, Will Host Call Tomorrow 3:11 p.m. Oct. 16, 2013 - benzinga.com
Pipeline Progress at Dynavax - Analyst Blog 11:10 a.m. Oct. 15, 2013 - Zacks.com
Dynavax Initiates Phase I Trial In Its Asthma Program 8:19 a.m. Oct. 10, 2013 - Seeking Alpha
Some Speculative Biotechs Making Major Moves 12:36 p.m. Sept. 25, 2013 - Seeking Alpha
Data on Dynavax' Heplisav - Analyst Blog 11:00 a.m. Sept. 25, 2013 - Zacks.com
Dynavax Says Phase 3 Data on HEPLISAV for Adults Age 40-70 Published in VACCINE 2:01 p.m. Sept. 24, 2013 - benzinga.com

Board Appointments, Ratings Upgrade, Successful Deployments, Submissions, and Conferences - Research Report on Health Care REIT, Ventas, Masimo, Dynavax, and Magellan 8:00 a.m. Dec. 24, 2013 - PR Newswire
Dynavax Announces Submission of Responses to EMA Day 120 List of Questions for HEPLISAV(TM) MAA 9:01 a.m. Dec. 19, 2013 - Marketwire
Stock Market Dailies: Teva Pharma Industries, Dynavax Technologies, Covidien, and Valeant Pharma Intl. 10:22 a.m. Dec. 11, 2013 - PR Newswire
Marketing Approval, Presentation Schedules, Supplier Agreement, and Management Changes - Research Report on ImmunoGen, Endologix, Unilife, Sangamo, and Dynavax 8:00 a.m. Dec. 5, 2013 - PR Newswire
Dynavax Announces Resignation of J. Tyler Martin From Board of Directors 4:46 p.m. Nov. 27, 2013 - Marketwire
ARIA, SIRI, DVAX and UNXL added to NASDAQ Active Stock Watch List at GSR 10:11 a.m. Nov. 25, 2013 - ACCESSWIRE
Technical Study: Teva Pharma Industries Ltd, Covidien PLC, Dynavax Technologies Corp., and Valeant Pharma Intl. Inc. 8:00 a.m. Nov. 15, 2013 - PR Newswire
Dynavax Reports Third Quarter 2013 Financial Results 5:10 p.m. Nov. 7, 2013 - Marketwire
Market Briefing: Emerging Growth NASDAQ Stocks in the News 2:22 p.m. Oct. 25, 2013 - PR Newswire
Dynavax Prices Public Offerings of Common Stock and Series B Convertible Preferred Stock 7:30 a.m. Oct. 25, 2013 - Marketwire
Dynavax Announces Proposed Public Offerings of Common Stock and Series B Convertible Preferred Stock 3:01 p.m. Oct. 24, 2013 - Marketwire
Pre-Market Review: Teva Pharma Industries Ltd, Dynavax Technologies Corp., Covidien PLC, and Valeant Pharma Intl. Inc. 8:39 a.m. Oct. 24, 2013 - PR Newswire
Dynavax Reports on HEPLISAV(TM) Regulatory Path 4:09 p.m. Oct. 16, 2013 - Marketwire
Dynavax Initiates First Human Trial in Asthma Program 4:46 p.m. Oct. 9, 2013 - Marketwire
Today's Technical View: Avanir Pharmaceuticals Inc., Warner Chilcott PLC, Actavis Inc., and Dynavax Technologies Corp. 10:48 a.m. Oct. 1, 2013 - PR Newswire
Phase 3 Data on HEPLISAV(TM) in Adults Aged 40-70 and Patients With Chronic Kidney Disease Published in VACCINE 3:00 p.m. Sept. 24, 2013 - Marketwire
Today's Research: Avanir Pharmaceuticals Inc., Warner Chilcott plc, Actavis Inc., and Dynavax Technologies Corp. 7:00 a.m. Aug. 28, 2013 - PR Newswire
Zeldes Haeggquist & Eck, LLP Announces Investigation of Dynavax Technologies Corporation 8:01 a.m. Aug. 16, 2013 - BusinessWire
Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Dynavax Technologies Corporation 9:54 p.m. Aug. 13, 2013 - BusinessWire
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Dynavax Technologies Corporation of Class Action Lawsuit and Deadline of August 19, 2013 to Seek Lead Plaintiff Position 3:37 p.m. Aug. 12, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jacquie Lawson's Advent Calendar Delights Fans for 17th Year

A Festive Tradition with a Twist The Jacquie Lawson Advent calendar is back for its 17th season, and it's no ho-hum affair. This time, the scene is set against the breathtaking backdrop of England's Lake District. If you've been yearning for a bit of that classic literary and natural charm, this is your ticket—minus the airfare. The calendar isn't just a countdown; it's...

YSS Faces Legal Heat Over Misleading Investor Claims

YSS Investors Navigate Legal Waters as Class Action Looms Taking a slug of coffee this morning and diving right into it—York Space Systems has found itself in hot water. They went public earlier this year with what was supposed to be a shining opportunity under the NYSE:YSS ticker, but it turns out that not everything in their IPO shined—and now SBS Law is stepping up...

Tata's $450M Bet on India's AI Infrastructure

The Big Bet on AI Infrastructure Here comes Tata Communications, tossing nearly USD 450 million into the pot, betting on a vision that could change India's digital backbone. This isn't just some drop in the bucket; they're talking about laying down 10,000 kilometers of fiber for India's AI super highway. It's a gutsy move, and frankly, it's about time someone shook things...

Cohere's CAD $7 Billion Raise Signals AI Power Shift

Changing the Game: Cohere's Massive Series E Raise There's a seismic shift happening up north, and it’s not the aurora borealis. Cohere just announced the initial close of a staggering CAD $7 billion Series E funding round, eyeing a CAD $35.7 billion valuation. If it pans out, it’d be the kind of cash grab that's never been seen in Canadian tech history. Why This...

BioMarin Strikes Deal for New Fabry Disease Therapy

BioMarin's Latest Moves in Rare Disease Therapies Now here's a plot twist in the biotechnology landscape. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) just did what they do best—snagging rights to a promising enzyme therapy aimed at turning the tide for Fabry disease. In a deal that spoke volumes about their intentions, BioMarin is forking over a cool $70 million upfront...

Ball Corp to Steal the Spotlight at 2026 Baird Event

Ball Corporation's Big Moment at Baird 2026 Did you hear the rumble in the aluminum jungle? That's Ball Corporation (NYSE: BALL) gearing up to take the stage at the Baird 2026 Global Industrial Conference on November 12. The big wigs, Ron Lewis and Dan Rabbitt, CEO and CFO respectively, will throw down some serious wisdom at 7:55 a.m. Central Time. What'll they cover?...

IDrive Fortifies Data Protection with Top Certifications

Ramping up Security in a Complex World Data protection isn’t just yesterday’s crucial task—it's today's battlefield and tomorrow's war. Companies like IDrive are stepping up to the plate, offering solutions that are as sturdy as a brick wall. In a world where data breaches and hackers lurk like wolves in the shadows, the demand for secure, compliant data protection...

NeuroSense's Phase 3 Strategies for PrimeC Unveiled

How NeuroSense Is Poised to Tackle ALS Treatment Picture this: a room full of people holding their breath, hoping that NeuroSense can deliver the breakthrough they’ve been inching toward. It’s the kind of moment that gives you goosebumps if you've been sloggin' through the biotech trenches. NeuroSense’s pitch at NEALS is more than just a dog and pony show—it's a...

Bandwidth Welcomes Chip Schroeder: Key Board Makeover

Turning the Page at Bandwidth Bandwidth Inc. (NASDAQ:BAND) just shook up its executive roster by bringing in a heavy hitter. Chip Schroeder's landing on the board is a bold move from a strategic player in the cloud communications space. This guy's not your average board member; he's a veteran navigator through stormy market waters, and at Bandwidth, it seems he'll be...

Florida's Natural, Johnsonville Settle Bet Over Juice

No Such Thing as a Safe Bet When Milwaukee's Brewers edge out Tampa, it's not just about the wins and losses—it's about pride and a truckload of Florida's Natural orange juice cruising into Wisconsin. Who knew baseball could drive trades not just between players, but entire industries? In this friendly wager, the stakes were both flavorful and steep, paying homage to...